1. Home
  2. OGEN vs KXIN Comparison

OGEN vs KXIN Comparison

Compare OGEN & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.59

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

KXIN

Kaixin Auto Holdings

HOLD

Current Price

$5.95

Market Cap

9.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGEN
KXIN
Founded
1996
2015
Country
United States
China
Employees
N/A
13
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
9.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
OGEN
KXIN
Price
$0.59
$5.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.5K
353.4K
Earning Date
05-11-2026
11-26-2019
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.11
52 Week High
$9.16
$22.00

Technical Indicators

Market Signals
Indicator
OGEN
KXIN
Relative Strength Index (RSI) 45.64 56.74
Support Level $0.56 $5.30
Resistance Level $0.66 $5.86
Average True Range (ATR) 0.04 0.48
MACD 0.00 0.07
Stochastic Oscillator 36.98 72.38

Price Performance

Historical Comparison
OGEN
KXIN

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.

Share on Social Networks: